Tykerb 00078-0671-19
Generic: Lapatinib
- Manufacturer
- Novartis Pharmaceuticals Corporation
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- August 3, 2016
- Listing Expires
- December 31, 2027
- Application
- NDA022059
Need to source Tykerb? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lapatinib Ditosylate | 250 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Protein Kinase Inhibitors [MoA]
Selected Package
00078-0671-19Selected150 TABLET in 1 BOTTLE (0078-0671-19)